Clinical outcomes related to the incidence of ventilator associated pneumonia in adults a cohort study VENTILATOR = LIFE SUPPORT but also VAP RISK. Up to 20% of ventilated patients >48 hrs develop VAP. Mortality? Can reach 50%. Here's what actually matters in ICU rounds Clinical and economic consequences of : Critical Care Medicine Mortality, incidence, and microbiological documentation of ventilated acquired pneumonia (VAP) in critically ill patients with COVID 19 or influenza ScienceDirect